Get a real taste and understanding of the business and culture of one of the world's great research-based cellular and gene therapy discovery and development companies.
EXPLORE MORECreative Biolabs has a tradition of commitment. To achieve efficient execution and regulatory approval, we offer careful considerations of your program for the development of a cellular or gene therapy product – now and in the future.
EXPLORE MORE HighlightsWe focus on unmet needs and develop novel cellular and gene drugs and solutions that offer significant benefits over existing options.
EXPLORE MORE HighlightsTo accelerate advanced breakthroughs of your projects, we offer broad range of platforms which enable our clients be free to tackle problems with cutting-edge technologies from different angles and in different methods.
EXPLORE MORE HighlightsUse the resources in our library to help you understand your options and make critical decisions for your study. We offer oncolytic virus, CAR-T, and dendritic cell related documents, as well as newsletter. If you don't find the answers you're looking for, contact us for additional assistance.
EXPLORE MORE Highlights
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
It is essential to ensure the safety of vaccines. In vitro safety assessment is a prerequisite for transferring candidate vaccines from laboratory to clinical practice, including product characterization, toxicology, adjuvant toxicity and stability, immunogenicity studies, and all aspects of microbial contamination testing. Creative Biolabs offers a range of pre-clinical in vitro tests to ensure these key attributes.
Creative Biolabs' safety assessments are conducted in the following categories:
In vitro safety studies conducted prior to the start of clinical trials (pre-clinical) identified potential safety issues and helped prevent possible harm to humans. Potential problems include toxicity caused by active ingredients or excipients, reactions to trace impurities (e.g., production substrates), and interactions between other vaccine components administered simultaneously.
In vitro safety assessment that Creative Biolabs includes:
With our professional team of experts, Creative Biolabs is dedicated to helping you identify the most promising candidate vaccines to help you enter the post-development phase.
For more details, please feel free to contact us for project quotations and more detailed information.
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
NEWSLETTER
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTER
NEW SOLUTION
CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTION
NOVEL TECHNOLOGY
Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGY
NEW SOLUTION
Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION
